检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《中西医结合心脑血管病杂志》2017年第12期1506-1508,共3页Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
摘 要:目的探讨中药鼻饲灌服联合常规西药治疗重症脑梗死的疗效。方法选取80例重症脑梗死病人,随机分为研究组和对照组,各40例。对照组采用依达拉奉治疗,研究组在对照组的基础上采用中药鼻饲灌服进行治疗。比较两组治疗有效率、治疗前后的神经功能缺损评分(NIHSS)、格拉斯哥昏迷评分(GCS)、血液流变学指标以及不良反应发生情况。结果研究组治疗总有效率为92.5%,对照组为72.5%,研究组高于对照组(P<0.05);治疗后,研究组的NIHSS评分高于对照组、GCS评分低于对照组(P<0.05);研究组全血高切黏度、全血低切黏度和血浆黏度均低于对照组(P<0.05);两组治疗期间无明显不良反应。结论中药鼻饲灌服联合常规西药治疗重症脑梗死的临床疗效显著,可有效改善血流状态,安全性高。Objective To observe the clinic efficacy of nasal-feeding Chinese medicine and conventional western medicine in the treatment of severe cerebral infarction.Methods Eighty patients with severe cerebral infarction were selected and divided randomly into two groups:control group(n =40)treated with edaravone,and treatment group(n =40)treated with edaravone and nasal-feeding Chinese medicine.The effective rate,National Institutes of Health Stroke Scale(NIHSS)scores,Glasgow Coma Score(GCS)before and after the treatment,blood rheology index and adverse reactions were observed.Results The total clinical effective rate was 92.5%in treatment group,which was significantly higher than that in control group(72.5%,P〈0.05).After the treatment,the NIHSS scores in treatment group were higher than that in control group(P〈0.05).The GCS score,the whole blood high shear viscosity,the whole blood low shear viscosity and plasma viscosity in treatment group were lower than that in control group(P〈0.05).There was no obsvious adverse reactions,in two groups during the treatment period.Conclusion The nasal-feeding Chinese medicine and conventional western medicine can improve the effective rate,and improve the blood flow state in patients with severe cerebral infarction.
关 键 词:重症脑梗死 中药鼻饲灌服 神经功能缺损 格拉斯哥昏迷评分
分 类 号:R743.33[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249